Label: HERPECIN PAIN RELIEF- allantoin, benzethonium chloride, lidocaine hcl gel

  • NDC Code(s): 71687-4000-1
  • Packager: Focus Consumer Healthcare, LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated April 1, 2021

If you are a consumer or patient please visit this version.

View All Sections
  • DRUG FACTS

  • ACTIVE INGREDIENT

    Allantoin 2%
    Benzethonium chlroide 0.2%
    Lidocaine HCl 4%

  • PURPOSE

    Skin Protectant

    Antiseptic

    Topical Anesthetic

  • USES

    ■ temporarily relieves pain and itching due to cold sores or fever blisters

    ■ temporarily relieves dryness; softens crusts (scabs) due to cold sores or fever blisters

    ■ first aid to help prevent infection in minor cuts, scrapes or burns due to cold sores or fever blisters

  • WARNINGS

    For external use only

    For external use only

    DO NOT USE

    Do not use over large areas of the body or on deep or puncture wounds, animal bites or serious burns

    WHEN USING THIS PRODUCT

    ■ keep out of eyes. Rinse with water to remove.

    ■ apply only to the affected area. Avoid applying directly inside the mouth.

    Stop use and ask a doctor if rash occurs, or if condition worsens or symptoms persist more than 7 days or clear up and occur again in a few days

    Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

  • DIRECTIONS

    adults and children 12 years of age or older:

    ■ clean the affected area

    ■ apply externally to the lips 1 to 3 times daily

    children under 12 years of age: Ask a doctor

  • OTHER INFORMATION

    ■ protect this product from excessive heat and direct sun

    ■ keep this carton as it contains important information

  • INACTIVE INGREDIENT

    aloe barbadensis leaf juice, bisabolol, disodium EDTA, ethylhexylglycerin, glycerin, hydrolyzed jojoba esters, hydroxyethylcellulose, lysine HCl, melissa officinalis extract, mentha piperita (peppermint) oil, mentha viridis (spearmint) leaf oil, potassium hydroxide, sclerotium gum, water, zingiber officinale (ginger) root extract

  • Principal Display Panel

    Maximum Strength - NEW

    Herpecin L

    Pain Relief

    Triple Action with Lidocain

    Tageted Spot Treatment

    for Cold Sores & Fever Blisters

    Protects Against Infection

    Numbs Cold Sore Pain & Itch at the Source

    Helps Preven Cracking

    Cold Sore Pain Reliever/Antiseptic/Lop Protectant Gel NET WT 0.15oz (4g)

    Herpecin Pain

  • INGREDIENTS AND APPEARANCE
    HERPECIN PAIN RELIEF 
    allantoin, benzethonium chloride, lidocaine hcl gel
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71687-4000
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LIDOCAINE HYDROCHLORIDE ANHYDROUS (UNII: EC2CNF7XFP) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS4 g  in 100 g
    ALLANTOIN (UNII: 344S277G0Z) (ALLANTOIN - UNII:344S277G0Z) ALLANTOIN2 g  in 100 g
    BENZETHONIUM CHLORIDE (UNII: PH41D05744) (BENZETHONIUM - UNII:1VU15B70BP) BENZETHONIUM CHLORIDE0.2 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    HYDROXYETHYL CELLULOSE, UNSPECIFIED (UNII: T4V6TWG28D)  
    LYSINE HYDROCHLORIDE, DL- (UNII: 81478P92RJ)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    LEVOMENOL (UNII: 24WE03BX2T)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    WATER (UNII: 059QF0KO0R)  
    GINGER (UNII: C5529G5JPQ)  
    HYDROLYZED JOJOBA ESTERS (ACID FORM) (UNII: UDR641JW8W)  
    SPEARMINT OIL (UNII: C3M81465G5)  
    MELISSA OFFICINALIS (UNII: YF70189L0N)  
    MENTHA PIPERITA (UNII: 79M2M2UDA9)  
    POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  
    BETASIZOFIRAN (UNII: 2X51AD1X3T)  
    Product Characteristics
    Color    Score    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71687-4000-11 in 1 CARTON06/11/2021
    14 g in 1 TUBE; Type 0: Not a Combination Product
    Image of Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart34806/11/2021
    Labeler - Focus Consumer Healthcare, LLC (080743737)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!